{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T12:11:27Z","timestamp":1788610287687,"version":"build-2803163510"},"reference-count":114,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.nano.2026.103002","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:52:20Z","timestamp":1785858740000},"page":"103002","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Engineered microorganisms and nanomaterials in cancer therapy: Emerging hybrid systems and translational challenges"],"prefix":"10.1016","volume":"76","author":[{"given":"Yuxi","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenhan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingyi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nano.2026.103002_bb0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0311233","article-title":"From colon wall to tumor niche: unraveling the microbiome\u2019s role in colorectal cancer progression","volume":"19","author":"Garc\u00eda Men\u00e9ndez","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.nano.2026.103002_bb0010","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.abn4948","article-title":"Fusobacterium nucleatum induces proliferation and migration in pancreatic cancer cells through host autocrine and paracrine signaling","volume":"15","author":"Udayasuryan","year":"2022","journal-title":"Sci Signal"},{"key":"10.1016\/j.nano.2026.103002_bb0015","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.05066-22","article-title":"The local tumor microbiome is associated with survival in late-stage colorectal cancer patients","volume":"11","author":"Debelius","year":"2023","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.nano.2026.103002_bb0020","series-title":"bioRxiv","article-title":"The tumor microbiome as a predictor of outcomes in patients with metastatic melanoma treated with immune checkpoint inhibitors","author":"Wheeler","year":"2023"},{"key":"10.1016\/j.nano.2026.103002_bb0025","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1158\/2767-9764.CRC-23-0170","article-title":"The tumor microbiome as a predictor of outcomes in patients with metastatic melanoma treated with immune checkpoint inhibitors","volume":"4","author":"Dravillas","year":"2024","journal-title":"Cancer Res Commun"},{"key":"10.1016\/j.nano.2026.103002_bb0030","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.synbio.2017.08.006","article-title":"Fundamental CRISPR-Cas9 tools and current applications in microbial systems","volume":"2","author":"Tian","year":"2017","journal-title":"Synth Syst Biotechnol"},{"key":"10.1016\/j.nano.2026.103002_bb0035","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1126\/science.add9667","article-title":"Engineering bacteria as interactive cancer therapies","volume":"378","author":"Gurbatri","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.nano.2026.103002_bb0040","doi-asserted-by":"crossref","first-page":"341","DOI":"10.2217\/fmb-2020-0245","article-title":"The next frontier of oncotherapy: accomplishing clinical translation of oncolytic bacteria through genetic engineering","volume":"16","author":"Dailey","year":"2021","journal-title":"Future Microbiol"},{"key":"10.1016\/j.nano.2026.103002_bb0045","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1126\/science.add7034","article-title":"Probiotic-guided CAR-T cells for solid tumor targeting","volume":"382","author":"Vincent","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.nano.2026.103002_bb0050","doi-asserted-by":"crossref","first-page":"4343","DOI":"10.1038\/s41467-024-48661-y","article-title":"Prodrug-conjugated tumor-seeking commensals for targeted cancer therapy","volume":"15","author":"Shen","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.nano.2026.103002_bb0055","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41392-023-01693-0","article-title":"Intratumoural microbiota: a new frontier in cancer development and therapy","volume":"9","author":"Cao","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.nano.2026.103002_bb0060","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/s41522-025-00717-7","article-title":"Fusobacterium nucleatum is enriched in invasive biofilms in colorectal cancer","volume":"11","author":"Queen","year":"2025","journal-title":"NPJ Biofilms Microbiomes"},{"key":"10.1016\/j.nano.2026.103002_bb0065","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/4639761","article-title":"Dual role of bacteria in carcinoma: stimulation and inhibition","volume":"2020","author":"Al-Hilu","year":"2020","journal-title":"Int J Microbiol"},{"key":"10.1016\/j.nano.2026.103002_bb0070","doi-asserted-by":"crossref","first-page":"5732","DOI":"10.1039\/D1BM00634G","article-title":"Bacteria-mediated cancer therapies: opportunities and challenges","volume":"9","author":"Yang","year":"2021","journal-title":"Biomater Sci"},{"key":"10.1016\/j.nano.2026.103002_bb0075","article-title":"Harnessing bacteria for tumor therapy: current advances and challenges","volume":"35","author":"Guo","year":"2024","journal-title":"Chin Chem Lett"},{"key":"10.1016\/j.nano.2026.103002_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.mib.2026.102727","article-title":"Advances in biocontainment strategies of engineered microbes for use in humans","volume":"91","author":"Fuerte-Stone","year":"2026","journal-title":"Curr Opin Microbiol"},{"key":"10.1016\/j.nano.2026.103002_bb0085","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1021\/sb500234s","article-title":"GeneGuard: a modular plasmid system designed for biosafety","volume":"4","author":"Wright","year":"2015","journal-title":"ACS Synth Biol"},{"key":"10.1016\/j.nano.2026.103002_bb0090","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.synbio.2024.12.005","article-title":"Environment signal-dependent biocontainment systems for engineered organisms: leveraging triggered responses and combinatorial systems","volume":"10","author":"Varma","year":"2025","journal-title":"Synth Syst Biotechnol"},{"key":"10.1016\/j.nano.2026.103002_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.micres.2024.127928","article-title":"From probiotic chassis to modification strategies, control and improvement of genetically engineered probiotics for inflammatory bowel disease","volume":"289","author":"Huang","year":"2024","journal-title":"Microbiol Res"},{"key":"10.1016\/j.nano.2026.103002_bb0100","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/s41564-024-01918-0","article-title":"Design and regulation of engineered bacteria for environmental release","volume":"10","author":"Chemla","year":"2025","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.nano.2026.103002_bb0105","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1177\/1758834016639873","article-title":"Targeted chemotherapy with nanoparticle albumin-bound paclitaxel (nab-paclitaxel) in metastatic breast cancer: which benefit for which patients?","volume":"8","author":"Palumbo","year":"2016","journal-title":"Ther Adv Med Oncol"},{"key":"10.1016\/j.nano.2026.103002_bb0110","article-title":"Nanoparticles for cancer therapy","volume":"114","author":"L\u00f6hr","year":"2017","journal-title":"Lakartidningen"},{"key":"10.1016\/j.nano.2026.103002_bb0115","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1021\/acs.molpharmaceut.5b00984","article-title":"Enhanced microwave hyperthermia of cancer cells with fullerene","volume":"13","author":"Sun","year":"2016","journal-title":"Mol Pharm"},{"key":"10.1016\/j.nano.2026.103002_bb0120","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1039\/C6NR08486A","article-title":"Design of nanocarriers for nanoscale drug delivery to enhance cancer treatment using hybrid polymer and lipid building blocks","volume":"9","author":"Zhang","year":"2017","journal-title":"Nanoscale"},{"key":"10.1016\/j.nano.2026.103002_bb0125","doi-asserted-by":"crossref","DOI":"10.1002\/EXP.20230147","article-title":"A perspective of lipid nanoparticles for RNA delivery","volume":"4","author":"Ma","year":"2024","journal-title":"Exploration"},{"key":"10.1016\/j.nano.2026.103002_bb0130","doi-asserted-by":"crossref","DOI":"10.1002\/EXP.20230164","article-title":"Innovative utilization of cell membrane-coated nanoparticles in precision cancer therapy","volume":"4","author":"He","year":"2024","journal-title":"Exploration"},{"key":"10.1016\/j.nano.2026.103002_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119513","article-title":"Metal organic framework coated MnO2 nanosheets delivering doxorubicin and self-activated DNAzyme for chemo-gene combinatorial treatment of cancer","volume":"585","author":"Nie","year":"2020","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2026.103002_bb0140","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1186\/s12951-025-03728-w","article-title":"Cinobufagin loaded Prussian blue-like nanoparticles for chemo\/gas therapy of multidrug resistant cancer","volume":"23","author":"Qiu","year":"2025","journal-title":"J Nanobiotechnol"},{"key":"10.1016\/j.nano.2026.103002_bb0145","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.532457","article-title":"Development of a hyaluronic acid-based nanocarrier incorporating doxorubicin and cisplatin as a pH-sensitive and CD44-targeted anti-breast cancer drug delivery system","volume":"11","author":"Yu","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.nano.2026.103002_bb0150","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/9363040","article-title":"Natural bioactive compounds: alternative approach to the treatment of glioblastoma multiforme","volume":"2017","author":"Desai","year":"2017","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.nano.2026.103002_bb0155","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201801362","article-title":"Overcoming the blood\u2013brain barrier: the role of nanomaterials in treating neurological diseases","volume":"30","author":"Furtado","year":"2018","journal-title":"Adv Mater"},{"key":"10.1016\/j.nano.2026.103002_bb0160","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12070630","article-title":"Stimuli-responsive nanomaterials for application in antitumor therapy and drug delivery","volume":"12","author":"Pham","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.nano.2026.103002_bb0165","doi-asserted-by":"crossref","first-page":"5837","DOI":"10.2147\/IJN.S466042","article-title":"Tumor cell-targeting and tumor microenvironment-responsive nanoplatforms for the multimodal imaging-guided photodynamic\/photothermal\/chemodynamic treatment of cervical cancer","volume":"19","author":"Wang","year":"2024","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.nano.2026.103002_bb0170","doi-asserted-by":"crossref","DOI":"10.3390\/nano10081617","article-title":"Toxicity of carbon nanomaterials and their potential application as drug delivery systems: in vitro studies in Caco-2 and MCF-7 cell lines","volume":"10","author":"Garriga","year":"2020","journal-title":"Nanomaterials (Basel)"},{"key":"10.1016\/j.nano.2026.103002_bb0175","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.tibtech.2016.09.002","article-title":"Optogenetic immunomodulation: shedding light on antitumor immunity","volume":"35","author":"Tan","year":"2017","journal-title":"Trends Biotechnol"},{"key":"10.1016\/j.nano.2026.103002_bb0180","doi-asserted-by":"crossref","DOI":"10.1002\/bmm2.70048","article-title":"Nanomaterials-mediated glycolysis rewriting to potentiate tumor immunotherapy","volume":"4","author":"Ma","year":"2026","journal-title":"BMEMat"},{"key":"10.1016\/j.nano.2026.103002_bb0185","article-title":"Nanoparticle-based nanomedicines to promote cancer immunotherapy: recent advances and future directions","volume":"15","author":"Liu","year":"2019","journal-title":"Small"},{"key":"10.1016\/j.nano.2026.103002_bb0190","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1513834","article-title":"Metal ions and nanomaterials for targeted bone cancer immunotherapy","volume":"16","author":"Qin","year":"2025","journal-title":"Front Immunol"},{"key":"10.1016\/j.nano.2026.103002_bb0195","doi-asserted-by":"crossref","first-page":"486","DOI":"10.20892\/j.issn.2095-3941.2018.0493","article-title":"Current applications and future prospects of nanotechnology in cancer immunotherapy","volume":"16","author":"Yan","year":"2019","journal-title":"Cancer Biol Med"},{"key":"10.1016\/j.nano.2026.103002_bb0200","doi-asserted-by":"crossref","DOI":"10.1002\/bmm2.12079","article-title":"Regulated cell death-amplified sonodynamic antitumor immune nanotherapeutics","volume":"2","author":"Zhou","year":"2024","journal-title":"BMEMat"},{"key":"10.1016\/j.nano.2026.103002_bb0205","doi-asserted-by":"crossref","first-page":"11688","DOI":"10.1021\/acs.langmuir.1c01607","article-title":"Effect of elasticity of silica capsules on cellular uptake","volume":"37","author":"Ma","year":"2021","journal-title":"Langmuir"},{"key":"10.1016\/j.nano.2026.103002_bb0210","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.biotechadv.2017.08.003","article-title":"In-vitro in-vivo correlation in nanomedicine: is protein corona the missing link?","volume":"35","author":"Jain","year":"2017","journal-title":"Biotechnol Adv"},{"key":"10.1016\/j.nano.2026.103002_bb0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2020.01.007","article-title":"Emerging well-tailored nanoparticulate delivery system based on in situ regulation of the protein corona","volume":"320","author":"Li","year":"2020","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2026.103002_bb0220","doi-asserted-by":"crossref","first-page":"9059","DOI":"10.1039\/D3CS00575E","article-title":"Computer-aided nanodrug discovery: recent progress and future prospects","volume":"53","author":"Zheng","year":"2024","journal-title":"Chem Soc Rev"},{"key":"10.1016\/j.nano.2026.103002_bb0225","article-title":"Synthesis, characterization, and investigation of corona formation of dipeptide-based nanomaterials","volume":"18","author":"Dikici","year":"2025","journal-title":"Materials (Basel)"},{"key":"10.1016\/j.nano.2026.103002_bb0230","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1021\/acsomega.2c06822","article-title":"Efficient one-pot solvothermal synthesis and characterization of zirconia nanoparticle-decorated reduced graphene oxide nanocomposites: evaluation of their enhanced anticancer activity toward human cancer cell lines","volume":"8","author":"Kadiyala","year":"2023","journal-title":"ACS Omega"},{"key":"10.1016\/j.nano.2026.103002_bb0235","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.actbio.2025.01.014","article-title":"Copper-based biomaterials for antitumor therapy: recent advances and perspectives","volume":"193","author":"Zhang","year":"2025","journal-title":"Acta Biomater"},{"key":"10.1016\/j.nano.2026.103002_bb0240","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2147\/IJN.S500261","article-title":"Cellulose based nano-scaffolds for targeted cancer therapies: current status and future perspective","volume":"20","author":"Li","year":"2025","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.nano.2026.103002_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2024.172240","article-title":"Impact of physicochemical properties on biological effects of lipid nanoparticles: are they completely safe?","volume":"927","author":"Yuan","year":"2024","journal-title":"Sci Total Environ"},{"key":"10.1016\/j.nano.2026.103002_bb0250","doi-asserted-by":"crossref","first-page":"5127","DOI":"10.1038\/s41467-022-32837-5","article-title":"Bacteria loaded with glucose polymer and photosensitive ICG silicon nanoparticles for glioblastoma photothermal immunotherapy","volume":"13","author":"Sun","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.nano.2026.103002_bb0255","doi-asserted-by":"crossref","first-page":"6437","DOI":"10.1021\/acsnano.4c16740","article-title":"Nanobiohybrid oncolytic bacteria with optimized intratumoral distribution for combined sono-photodynamic\/immunotherapy","volume":"19","author":"Zhang","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.nano.2026.103002_bb0260","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2147\/IJN.S462031","article-title":"Therapeutic innovations in nanomedicine: exploring the potential of magnetotactic bacteria and bacterial magnetosomes","volume":"20","author":"Yadav","year":"2025","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.nano.2026.103002_bb0265","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202403156","article-title":"Physiochemically and genetically engineered bacteria: instructive design principles and diverse applications","volume":"11","author":"Lin","year":"2024","journal-title":"Adv Sci"},{"key":"10.1016\/j.nano.2026.103002_bb0270","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1039\/D4BM01475H","article-title":"Structurally programmable, functionally tuneable dendrimers in biomedical applications","volume":"13","author":"Prakash","year":"2025","journal-title":"Biomater Sci"},{"key":"10.1016\/j.nano.2026.103002_bb0275","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1186\/s12951-024-02793-x","article-title":"The application of bacteria-nanomaterial hybrids in antitumor therapy","volume":"22","author":"Xiao","year":"2024","journal-title":"J Nanobiotechnol"},{"key":"10.1016\/j.nano.2026.103002_bb0280","article-title":"Synergistic brilliance: engineered bacteria and nanomedicine unite in cancer therapy","volume":"36","author":"Zhou","year":"2024","journal-title":"Adv Mater"},{"key":"10.1016\/j.nano.2026.103002_bb0285","article-title":"Nanomedicine hitchhiking on bacteria for treating tumors","volume":"2","author":"Zheng","year":"2024","journal-title":"BMEMat"},{"key":"10.1016\/j.nano.2026.103002_bb0290","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1097\/EDE.0000000000000471","article-title":"Review article: the role of molecular pathological epidemiology in the study of neoplastic and non-neoplastic diseases in the era of precision medicine","volume":"27","author":"Ogino","year":"2016","journal-title":"Epidemiology"},{"key":"10.1016\/j.nano.2026.103002_bb0295","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s00439-020-02235-2","article-title":"The microbiome, genetics, and gastrointestinal neoplasms: the evolving field of molecular pathological epidemiology to analyze the tumor-immune-microbiome interaction","volume":"140","author":"Mima","year":"2021","journal-title":"Hum Genet"},{"key":"10.1016\/j.nano.2026.103002_bb0300","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1146\/annurev-pathmechdis-012418-012818","article-title":"Insights into pathogenic interactions among environment, host, and tumor at the crossroads of molecular pathology and epidemiology","volume":"14","author":"Ogino","year":"2019","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.nano.2026.103002_bb0305","doi-asserted-by":"crossref","DOI":"10.1093\/carcin\/bgaf025","article-title":"Current challenges and potential opportunities for interception and prevention of head and neck cancer","volume":"46","author":"El-Bayoumy","year":"2025","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.nano.2026.103002_bb0310","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.cell.2017.07.008","article-title":"Fusobacterium nucleatum promotes chemoresistance to colorectal cancer by modulating autophagy","volume":"170","author":"Yu","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.nano.2026.103002_bb0315","doi-asserted-by":"crossref","first-page":"557","DOI":"10.3748\/wjg.v22.i2.557","article-title":"Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer","volume":"22","author":"Nosho","year":"2016","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.nano.2026.103002_bb0320","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1097\/CM9.0000000000003617","article-title":"Intestinal dysbiosis and colorectal cancer","volume":"138","author":"Kang","year":"2025","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.nano.2026.103002_bb0325","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/s00262-025-04048-6","article-title":"Analyses of single-cell RNA sequencing uncover the role of intratumoral Helicobacter pylori in shaping tumor progression and immunity in gastric cancer","volume":"74","author":"Xu","year":"2025","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.nano.2026.103002_bb0330","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1007\/s10529-016-2105-4","article-title":"Organic two-photon nanoparticles modulate reactive oxygen species, intracellular calcium concentration, and mitochondrial membrane potential during apoptosis of human gastric carcinoma SGC-7901 cells","volume":"38","author":"Chen","year":"2016","journal-title":"Biotechnol Lett"},{"key":"10.1016\/j.nano.2026.103002_bb0335","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jconrel.2016.04.011","article-title":"Application of vasoactive and matrix-modifying drugs can improve polyplex delivery to tumors upon intravenous administration","volume":"232","author":"Durymanov","year":"2016","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2026.103002_bb0340","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jconrel.2016.06.044","article-title":"Inhibition of the cancer-associated TASK-3 channels by magnetically induced thermal release of tetrandrine from a polymeric drug carrier","volume":"237","author":"Shi","year":"2016","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2026.103002_bb0345","doi-asserted-by":"crossref","first-page":"6401","DOI":"10.2147\/IJN.S101285","article-title":"Upregulation of Akt\/NF-\u03baB-regulated inflammation and Akt\/Bad-related apoptosis signaling pathway involved in hepatic carcinoma process: suppression by carnosic acid nanoparticle","volume":"11","author":"Tang","year":"2016","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.nano.2026.103002_bb0350","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/imm.13793","article-title":"Immunotherapy and the ovarian cancer microenvironment: exploring potential strategies for enhanced treatment efficacy","volume":"173","author":"Wang","year":"2024","journal-title":"Immunology"},{"key":"10.1016\/j.nano.2026.103002_bb0355","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.immuni.2016.06.001","article-title":"Resistance mechanisms to immune-checkpoint blockade in cancer: tumor-intrinsic and tumor-extrinsic factors","volume":"44","author":"Pitt","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.nano.2026.103002_bb0360","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.canlet.2015.12.028","article-title":"Commensal bacteria modulate the tumor microenvironment","volume":"380","author":"Poutahidis","year":"2016","journal-title":"Cancer Lett"},{"key":"10.1016\/j.nano.2026.103002_bb0365","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1016\/j.jmb.2016.03.021","article-title":"Shaping the immune landscape in cancer by galectin-driven regulatory pathways","volume":"428","author":"Rabinovich","year":"2016","journal-title":"J Mol Biol"},{"key":"10.1016\/j.nano.2026.103002_bb0370","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/s41591-019-0458-7","article-title":"Metagenomic and metabolomic analyses reveal distinct stage-specific phenotypes of the gut microbiota in colorectal cancer","volume":"25","author":"Yachida","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/j.nano.2026.103002_bb0375","doi-asserted-by":"crossref","DOI":"10.1093\/gigascience\/giz045","article-title":"A multi-omics data simulator for complex disease studies and its application to evaluate multi-omics data analysis methods for disease classification","volume":"8","author":"Chung","year":"2019","journal-title":"GigaScience"},{"key":"10.1016\/j.nano.2026.103002_bb0380","doi-asserted-by":"crossref","first-page":"e00013","DOI":"10.1128\/mSystems.00013-15","article-title":"Metabolic model-based integration of microbiome taxonomic and metabolomic profiles elucidates mechanistic links between ecological and metabolic variation","volume":"1","author":"Noecker","year":"2016","journal-title":"mSystems"},{"key":"10.1016\/j.nano.2026.103002_bb0385","doi-asserted-by":"crossref","first-page":"e00805","DOI":"10.1128\/msystems.00805-24","article-title":"Multi-omics analysis reveals associations between gut microbiota and host transcriptome in colon cancer patients","volume":"10","author":"Qin","year":"2025","journal-title":"mSystems"},{"key":"10.1016\/j.nano.2026.103002_bb0390","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaa3519","article-title":"Programmable probiotics for detection of cancer in urine","volume":"7","author":"Danino","year":"2015","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.nano.2026.103002_bb0395","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1126\/science.adf3974","article-title":"Engineered bacteria detect tumor DNA","volume":"381","author":"Cooper","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.nano.2026.103002_bb0400","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1002\/bit.26006","article-title":"Engineered bacteria detect spatial profiles in glucose concentration within solid tumor cell masses","volume":"113","author":"Panteli","year":"2016","journal-title":"Biotechnol Bioeng"},{"key":"10.1016\/j.nano.2026.103002_bb0405","doi-asserted-by":"crossref","first-page":"591","DOI":"10.2147\/IJN.S591943","article-title":"DNA aptamer-functionalized fluorescent silica nanoparticles: a robust strategy for specific detection and bioimaging of HER2-overexpressing breast cancer","volume":"21","author":"Tan","year":"2026","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.nano.2026.103002_bb0410","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1016\/j.ebiom.2015.10.028","article-title":"A novel genomic alteration of LSAMP associates with aggressive prostate cancer in African American men","volume":"2","author":"Petrovics","year":"2015","journal-title":"EBioMedicine"},{"key":"10.1016\/j.nano.2026.103002_bb0415","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s12094-016-1557-2","article-title":"Patient-derived xenografts for childhood solid tumors: a valuable tool to test new drugs and personalize treatments","volume":"19","author":"Zarzosa","year":"2017","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.nano.2026.103002_bb0420","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2024.1514399","article-title":"Advances and prospects of precision nanomedicine in personalized tumor theranostics","volume":"12","author":"Mao","year":"2024","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.nano.2026.103002_bb0425","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1002\/cncr.30539","article-title":"Unique prevalence of oncogenic genetic alterations in young patients with lung adenocarcinoma","volume":"123","author":"Hida","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.nano.2026.103002_bb0430","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1088\/0031-9155\/61\/7\/2926","article-title":"Real-time monitoring of focused ultrasound blood-brain barrier opening via subharmonic acoustic emission detection: implementation of confocal dual-frequency piezoelectric transducers","volume":"61","author":"Tsai","year":"2016","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.nano.2026.103002_bb0435","doi-asserted-by":"crossref","first-page":"16043","DOI":"10.1021\/acsami.7b04447","article-title":"Acidity-triggered tumor retention\/internalization of chimeric peptide for enhanced photodynamic therapy and real-time monitoring of therapeutic effects","volume":"9","author":"Han","year":"2017","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.nano.2026.103002_bb0440","doi-asserted-by":"crossref","DOI":"10.3390\/s20226496","article-title":"Closed-loop temperature control based on fiber Bragg grating sensors for laser ablation of hepatic tissue","volume":"20","author":"Korganbayev","year":"2020","journal-title":"Sensors (Basel, Switzerland)"},{"key":"10.1016\/j.nano.2026.103002_bb0445","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1158\/1078-0432.CCR-15-2667","article-title":"Molecular pathways: mechanism of action for talimogene laherparepvec, a new oncolytic virus immunotherapy","volume":"22","author":"Kohlhapp","year":"2016","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.nano.2026.103002_bb0450","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/j.tibtech.2024.06.011","article-title":"Engineered bacterial therapeutics with material solutions","volume":"42","author":"Dey","year":"2024","journal-title":"Trends Biotechnol"},{"key":"10.1016\/j.nano.2026.103002_bb0455","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.tibtech.2016.04.013","article-title":"Scientific opinion on risk assessment of synthetic biology","volume":"34","author":"Epstein","year":"2016","journal-title":"Trends Biotechnol"},{"key":"10.1016\/j.nano.2026.103002_bb0460","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1007\/s11948-016-9868-9","article-title":"Synthetic biology, genome editing, and the risk of bioterrorism","volume":"23","author":"Ahteensuu","year":"2017","journal-title":"Sci Eng Ethics"},{"key":"10.1016\/j.nano.2026.103002_bb0465","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/s41589-018-0056-x","article-title":"Next-generation biocontainment systems for engineered organisms","volume":"14","author":"Lee","year":"2018","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.nano.2026.103002_bb0470","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1208\/s12249-024-02843-5","article-title":"Stealth nanocarriers in cancer therapy: a comprehensive review of design, functionality, and clinical applications","volume":"25","author":"Saadh","year":"2024","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.nano.2026.103002_bb0475","doi-asserted-by":"crossref","first-page":"5705","DOI":"10.1039\/D5TB00086F","article-title":"ZIF-8\/doxorubicin nanoparticles camouflaged with Cucurbita-derived exosomes for targeted prostate cancer therapy","volume":"13","author":"Saffar","year":"2025","journal-title":"J Mater Chem B"},{"key":"10.1016\/j.nano.2026.103002_bb0480","doi-asserted-by":"crossref","DOI":"10.1088\/1758-5090\/ab6034","article-title":"Vat polymerization-based bioprinting: process, materials, applications and regulatory challenges","volume":"12","author":"Ng","year":"2020","journal-title":"Biofabrication"},{"key":"10.1016\/j.nano.2026.103002_bb0485","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1177\/1091581820977846","article-title":"Development and regulatory challenges for peptide therapeutics","volume":"40","author":"Zane","year":"2021","journal-title":"Int J Toxicol"},{"key":"10.1016\/j.nano.2026.103002_bb0490","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pdig.0000189","article-title":"Beyond high hopes: a scoping review of the 2019\u20132021 scientific discourse on machine learning in medical imaging","volume":"2","author":"Nittas","year":"2023","journal-title":"PLOS Digit Health"},{"key":"10.1016\/j.nano.2026.103002_bb0495","article-title":"Software as a medical device in digestive healthcare: regulatory challenges and ethical implications","volume":"14","author":"Mascarenhas","year":"2024","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.nano.2026.103002_bb0500","doi-asserted-by":"crossref","DOI":"10.1016\/j.biotechadv.2025.108564","article-title":"Re-imagining human cell culture media: challenges, innovations, and future directions","volume":"81","author":"Wijerathna-Yapa","year":"2025","journal-title":"Biotechnol Adv"},{"key":"10.1016\/j.nano.2026.103002_bb0505","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/wnan.30","article-title":"The public acceptance of nanomedicine: a personal perspective","volume":"1","author":"Berube","year":"2009","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"key":"10.1016\/j.nano.2026.103002_bb0510","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2023.1163392","article-title":"Ethical and legal challenges in nanomedical innovations: a scoping review","volume":"14","author":"Wasti","year":"2023","journal-title":"Front Genet"},{"key":"10.1016\/j.nano.2026.103002_bb0515","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1038\/s41467-020-15508-1","article-title":"Developing a new class of engineered live bacterial therapeutics to treat human diseases","volume":"11","author":"Charbonneau","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.nano.2026.103002_bb0520","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120807","article-title":"PLGA-based nanomedicines manufacturing: technologies overview and challenges in industrial scale-up","volume":"605","author":"Operti","year":"2021","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2026.103002_bb0525","doi-asserted-by":"crossref","DOI":"10.1128\/cmr.00194-23","article-title":"Review of BCG immunotherapy for bladder cancer","volume":"38","author":"Liatsos","year":"2025","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.nano.2026.103002_bb0530","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1158\/1078-0432.CCR-20-2065","article-title":"Intratumoral injection of Clostridium novyi-NT spores in patients with treatment-refractory advanced solid tumors","volume":"27","author":"Janku","year":"2021","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.nano.2026.103002_bb0535","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1158\/1078-0432.CCR-23-0118","article-title":"Phase I study of SYNB1891, an engineered Escherichia coli Nissle strain expressing a STING agonist, with and without atezolizumab in advanced malignancies","volume":"29","author":"Luke","year":"2023","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.nano.2026.103002_bb0540","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2018.00790","article-title":"Current trends and challenges in the clinical translation of nanoparticulate nanomedicines: pathways for translational development and commercialization","volume":"9","author":"Hua","year":"2018","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.nano.2026.103002_bb0545","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jconrel.2020.07.007","article-title":"Delivering the power of nanomedicine to patients today","volume":"326","author":"Germain","year":"2020","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2026.103002_bb0550","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.114083","article-title":"Clinical translation of nanomedicines: challenges, opportunities, and keys","volume":"181","author":"Younis","year":"2022","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.nano.2026.103002_bb0555","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/nrc.2016.108","article-title":"Cancer nanomedicine: progress, challenges and opportunities","volume":"17","author":"Shi","year":"2017","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.nano.2026.103002_bb0560","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2022.1000873","article-title":"Microbiome engineering: engineered live biotherapeutic products for treating human disease","volume":"10","author":"Rutter","year":"2022","journal-title":"Front Bioeng Biotechnol"},{"key":"10.1016\/j.nano.2026.103002_bb0565","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1016\/j.mayocp.2017.10.004","article-title":"Microbiome at the frontier of personalized medicine","volume":"92","author":"Kashyap","year":"2017","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.nano.2026.103002_bb0570","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s41522-025-00882-9","article-title":"CRISPR-engineered microbiome: living therapeutics revolutionize blood cancer immunotherapy","volume":"12","author":"Cheng","year":"2026","journal-title":"NPJ Biofilms Microbiomes"}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963426001036?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963426001036?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T11:13:29Z","timestamp":1788606809000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963426001036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":114,"alternative-id":["S1549963426001036"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2026.103002","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Engineered microorganisms and nanomaterials in cancer therapy: Emerging hybrid systems and translational challenges","name":"articletitle","label":"Article Title"},{"value":"Nanomedicine: Nanotechnology, Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nano.2026.103002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103002"}}